Malhotra Anshoo, Kumar Pardeep, Sharma Sarika, Dhawan Davinder K
Nuclear Medicine, Centre for Emerging Areas in Science and Technology, Panjab University, Chandigarh 160014, India.
Hell J Nucl Med. 2010 Sep-Dec;13(3):229-32.
The present study was designed to develop stable and economically competitive radioactive technetium-99m macro-aggregates of albumin ((99m)Tc-MAA) which could be used for imaging of lungs. Macro-aggregates were freshly prepared and labeled with (99m)Tc pertechnetate by following the standard protocol which included incubation of formulation at 80(o) C for 10 min. We studied 7 rats in every experiment. The rats were injected intravenously with (99m)Tc MAA and were sacrificed after 10 min to study its distribution in the lungs and other non target tissues using gamma ray spectrometer. This standard protocol was further experimented upon in order to achieve high target to non target ratio. Different formulations were prepared by incubating them at 80 degrees for different incubation times of 5, 10, 15, 20, 25 and 30 min. Formulation of MAA prepared by incubating at 80 degrees for 20 min labeled with (99m)Tc showed the highest target to non target ratio. Another group of rats that received the above formulation were sacrificed after two additional time intervals of 5 and 15 min. The target to non target ratio was high in animals sacrificed after 5 min of injecting them with (99m)Tc the MAA formulation prepared by heating at 80 degrees for 20 min as compared to animals sacrificed after 10 and 15 min. Formulations of MAA following storage at room temperatures which varied from 5(o)C to 18(o)C, for different time durations 1, 2 and 9 days were also evaluated for their ability to be reused after reheating and labeling with (99m)Tc. The formulation of MAA kept for 9 days showed the best target to non-target ratio. The present study suggests that MAA once prepared can be reused following labeling with (99m)Tc even after 9 days of storage with better target to non target ratio as compared to storage timer period of 1 and 2 days.
本研究旨在开发稳定且具有经济竞争力的放射性锝-99m标记白蛋白大颗粒((99m)Tc-MAA),用于肺部成像。大颗粒是按照标准方案新鲜制备并用高锝酸盐(99m)Tc进行标记的,该方案包括将制剂在80(o)C孵育10分钟。每个实验中我们研究7只大鼠。给大鼠静脉注射(99m)Tc MAA,10分钟后处死,使用γ射线光谱仪研究其在肺部和其他非靶组织中的分布。为了实现高靶非靶比,对该标准方案进行了进一步实验。通过在80℃孵育不同时间(5、10、15、20、25和30分钟)制备不同制剂。在80℃孵育20分钟后用(99m)Tc标记的MAA制剂显示出最高的靶非靶比。另一组接受上述制剂的大鼠在另外两个时间间隔(5和15分钟)后处死。与在注射(99m)Tc标记的MAA制剂(通过在80℃加热20分钟制备)10分钟和15分钟后处死的动物相比,在注射后5分钟处死的动物中靶非靶比很高。还评估了在5(o)C至18(o)C的室温下储存不同时长(1、2和9天)后的MAA制剂在重新加热并用(99m)Tc标记后再利用的能力。保存9天的MAA制剂显示出最佳的靶非靶比。本研究表明,MAA一旦制备,在用(99m)Tc标记后即使储存9天也可再利用,与储存1天和2天相比,具有更好的靶非靶比。